Ventricular Assist Device Industry Outlook 2025-2029: Market Set to Cross $3.87 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Ventricular Assist Device Market Size By 2025?
The market size of the ventricular assist device has seen rapid expansion in recent years. A growth from $2.12 billion in 2024 to $2.37 billion in 2025 is projected, reflecting a compound annual growth rate (CAGR) of 11.8%. The growth witnessed in the past years is due to an upward trend in heart failure cases and an increasing need for organ transplantation procedures.

How Big Is the Ventricular Assist Device Market Size Expected to Grow by 2029?
Expectations are high for a swift expansion of the ventricular assist device market in the coming years, with projections seeing this sector swelling to a worth of $3.87 billion by 2029, boasting a compound annual growth rate (CAGR) of 13.0%. This anticipated surge during the forecast period can be traced back to the escalation in demand for destination therapy, an aging demographic, rising health care spending, and heightened awareness about treatments for heart failure. Looking to the forecast period, key trends present include efforts to extend the effective lifespan of VADs, downsizing of these devices, development of advanced pump technologies, elevated emphasis on safety and effectiveness of VADs, a drive to decrease their side effects, and a rise in the use of percutaneously inserted ventricular assist devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Which Key Market Drivers Powering Ventricular Assist Device Market Expansion and Growth?
The prevalent growth in cardiovascular conditions is propelling the expansion of the ventricular assist device market. Such heart diseases, instigated by hypertension, smoking, raised cholesterol, lack of physical activity, among other reasons. The escalation of cardiovascular conditions can also be linked to non-infectious diseases such as diabetes, chronic lung disease, and heart complications due to elevated blood pressure levels. The growing occurrence of cardiovascular diseases is likely to heighten the need for ventricular assist devices, acting as a crucial lifeline for critically ill heart patients. For example, as per the National Library of Medicine, a federal authority in the US in October 2022, by 2035, it's projected that 45.1% of the US population will be diagnosed with cardiovascular diseases. The overall expenses linked to these heart diseases are anticipated to hit $1.1 trillion come 2035. Accordingly, the rise in cardiovascular diseases prevalence is likely to bolster the need for ventricular assist devices throughout the predicted period.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

What Are the Key Trends Driving Ventricular Assist Device Market Growth?
The utilization of percutaneously inserted ventricular assist devices is progressively increasing in the market. Defined as a non-pulsatile axial flow pump, this device is inserted across the aortic valve to pump blood from the left ventricle. This type of ventricular assist device (VAD) effectively reduces the load on the left ventricle and myocardial oxygen consumption, thereby increasing cardiac output and reducing left ventricular end-diastolic pressure. As an illustration, Abiomed Inc., a medical device company based in the US, launched its own version of the percutaneous VAD, Impella, for deserving pediatric patients in the USA in August 2022. This device delivers adequate cardiac support for patients with a failing left ventricle. It is also beneficial as a replacement for extracorporeal membrane oxygenation (ECMO) or as a co-treatment for hemodynamic improvement.

What Are the Emerging Segments in the Ventricular Assist Device Market?
The ventricular assist device market covered in this report is segmented -

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).
2) By Type: Pulsatile Flow, Continuous Flow
3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices
4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy
5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:
1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs
2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs
3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Who Are the Global Leaders in the Ventricular Assist Device Market?
Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Which are the Top Profitable Regional Markets for the Ventricular Assist Device Industry?
North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6680

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.